Our Team
Scientists and builders who originate conviction.
MEET THE TEAM
BETHANY WRIGHT
Finance Associate
NATE DAVIS
Associate
MATTHEW HAMMOND, PhD
Principal
J. MICHAEL RYAN, MD
Entrepreneur in Residence
JONATHAN PRITZ, PhD
Senior Associate
PETER BALOGH
Junior Associate
BETHANY WRIGHT
Finance Associate
Bethany is a Finance Associate at RA Capital Management. Her primarily responsibilities are to assist with all finance operations related to the Firm. She previously held posts as an Accounts Receivable Analyst at the MFA Companies and as an Administrative Assistant at the Massachusetts Eye and Ear Infirmary. She holds a BS in Corporate Finance & Accounting from Salem State University.
NATE DAVIS
Associate
Nate Davis is an Associate with the TechAtlas division of RA Capital Management. Nate’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Nate has a BS in Biological Sciences from University of Vermont. Nate previously worked as an Investment Analyst at Wolfram Ventures.
MATTHEW HAMMOND, PhD
Principal
Matthew Hammond is a Principal on the Investment Team at RA Capital Management. Matthew works on both public and private healthcare companies and serves as a Director on the Board of Cerebral Therapeutics. Matthew holds a BS in Environmental Health Science from the University of Georgia and both a PhD in Biomedical Science and an MBA with a concentration in Finance from the University of Connecticut. His graduate research investigated innate immune responses after intracerebral hemorrhage.
J. MICHAEL RYAN, MD
Entrepreneur in Residence
Michael Ryan is an EIR at RA Capital. He most recently served as Chief Medical Officer for Rodin Therapeutics, where he led all clinical development activities from first-in-human through patient studies until the acquisition by Alkermes. He has held multiple senior level clinical development positions including Chief Medical Officer at Asceneuron SA and Neurodegeneration Therapeutic Area Head at Novartis. Michael received his undergraduate degree at Georgetown University and his medical degree at the Medical University of South Carolina. He completed an internship in Internal Medicine and residency in Psychiatry at the University of Utah Health Sciences Center. Dr. Ryan was also a fellow in Geriatric Psychiatry and Neuropsychiatry at Dartmouth-Hitchcock Medical Center. He was a faculty member at the University of Rochester School of Medicine prior to joining Merck Research Laboratories in 2004.
JONATHAN PRITZ, PhD
Senior Associate
Jonathan Pritz is a Senior Associate with the Oncology Team within the TechAtlas division of RA Capital Management. Jonathan’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Jonathan holds a BS in Microbiology and Cell Science from the University of Florida, and a PhD in Biological Chemistry and Molecular Pharmacology from Harvard University. His graduate research investigated chemical activators of cell death in cancer.
PETER BALOGH
Junior Associate
Peter Balogh is a Junior Associate within the TechAtlas division of RA Capital Management. Peter’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Peter has a BS in Biology with minors in both Chemistry and Spanish for the Medical Professions from the University of North Carolina at Chapel Hill.